All posts tagged: Cardiovascular Disease

Red meat once helped human evolution but now carries serious risks

Red meat once helped human evolution but now carries serious risks

Red meat has long occupied a near-mythic place in the story of human evolution. It is often cast as the food that helped make us human, feeding bigger brains, stronger bodies, and more complex societies. But a sweeping new review in The Quarterly Review of Biology argues that the story no longer ends there. The same food source that may once have helped early humans survive is now tied to chronic disease, environmental damage, and a global food system whose scale looks nothing like anything in the human past. In the review, Juston Jaco, Kalyan Banda, Ajit Varki, and Pascal Gagneux from the University of California, San Diego pull together evidence from archaeology, anthropology, nutrition, epidemiology, and molecular biology. Their conclusion is not that meat was a mistake. It is that modern red meat consumption has drifted far from its original biological and ecological setting. “The nature, scale, and context of red meat consumption today differ drastically from those of our evolutionary past,” the authors write. As Homo sapiens increasingly relied on animal-derived foods—whether hunted …

Once-daily pill called enlicitide lowers bad cholesterol levels by 60%

Once-daily pill called enlicitide lowers bad cholesterol levels by 60%

A new experimental pill may soon change how you lower cholesterol. Researchers at UT Southwestern Medical Center report that an oral drug called enlicitide cut levels of low-density lipoprotein, or LDL, cholesterol by nearly 60% in a large clinical trial. The findings were published in The New England Journal of Medicine and could lead to a simpler way to prevent heart attacks and strokes. The clinical trial was led by Dr. Ann Marie Navar, an Associate Professor in the Department of Internal Medicine and the Department of Public Health. The clinical trial was funded by Merck and involved nearly 3,000 adults at high risk for heart disease. According to Navar, “Currently less than half of patients with established atherosclerotic cardiovascular disease are able to reach their LDL cholesterol goals. With an oral agent that has proven this to be so effective, we now have a vehicle that can significantly help us prevent both heart attacks and strokes in the general population.” Ann Marie Navar, M.D., Ph.D., is a cardiologist and Associate Professor of Internal Medicine …